Stock Quality:
Last 7 days
-2.5%
Last 30 days
3.8%
Last 90 days
-21.0%
Trailing 12 Months
-28.4%
ELAN RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Revenue Breakdown
| |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||
|
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 4.4B | 4.5B | 4.5B | 4.4B |
2023 | 4.4B | 4.3B | 4.4B | 4.4B |
2022 | 4.7B | 4.6B | 4.5B | 4.4B |
2021 | 3.9B | 4.6B | 4.8B | 4.8B |
2020 | 3.0B | 2.8B | 2.9B | 3.3B |
2019 | 3.1B | 3.1B | 3.1B | 3.1B |
2018 | 2.9B | 3.0B | 3.0B | 3.1B |
2017 | 2.9B | 2.9B | 2.9B | 2.9B |
2016 | 0 | 0 | 0 | 2.9B |
2015 | 0 | 0 | 0 | 2.9B |
CEO | Mr. Jeffrey N. Simmons |
---|---|
WEBSITE | elanco.com |
SECTOR | Healthcare |
INDUSTRY | Drug Manufacturers Specialty & Generic |
EMPLOYEES | 9000 |